Measuring rates of brain atrophy from serial magnetic resonance imaging (MRI) scans is gaining acceptance as a valid noninvasive biomarker of disease progression in neurodegenerative conditions. To date, the two most widely used measurement techniques are, manual segmentation of specific structures (e.g. hippocampus), or semi-automated image registration and subtraction to generate whole brain atrophy rates. Both of these techniques, while useful, have important limitations in neurodegenerative conditions that are characterized by atrophy of select regions of the brain. A prototypical neurodegenerative condition that is characterized by selective atrophy is frontal temporal dementia (FTD). A class of computational techniques that we refer to in this application as tensor based morphometry (TBM) seem ideally suited to measure atrophy rates of defined regions/lobes of the brain from serial MRI scans. We have developed a prototype version of a TBM algorithm and the associated software code, but have not yet performed the clinical comparison studies necessary for validation. Another largely ignored but important technical topic addressed in this application is rigorous evaluation of sources of and methods to correct geometric distortion in MR images. This project has two major goals. The first is to optimize our prototype TBM method and to compare it to other approaches for validation purposes. We will also evaluate methods for correcting geometric distortion in MRI. This validation and testing work is the objective of Aims 1 and 2. The second major goal is to prospectively test the hypothesis that the regional atrophy rate measurement method developed during the technical phase of the project will provide group specific signatures that are characteristic of particular clinical phenotypes, specifically normal aging, AD, and FTD. We will test the hypothesis that TBM regional atrophy rate measures show greater clinical group specificity that global atrophy rate measures. We will also include pathological verification and correlation when possible.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG016574-10
Application #
7618216
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2008-05-01
Budget End
2009-04-30
Support Year
10
Fiscal Year
2008
Total Cost
$195,992
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Knopman, David S; Lundt, Emily S; Therneau, Terry M et al. (2018) Joint associations of ?-amyloidosis and cortical thickness with cognition. Neurobiol Aging 65:121-131
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Ferman, Tanis J; Aoki, Naoya; Crook, Julia E et al. (2018) The limbic and neocortical contribution of ?-synuclein, tau, and amyloid ? to disease duration in dementia with Lewy bodies. Alzheimers Dement 14:330-339
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Besser, Lilah; Kukull, Walter; Knopman, David S et al. (2018) Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer Dis Assoc Disord 32:351-358
Zhou, Zilu; Wang, Weixin; Wang, Li-San et al. (2018) Integrative DNA copy number detection and genotyping from sequencing and array-based platforms. Bioinformatics 34:2349-2355
Vemuri, Prashanthi; Lesnick, Timothy G; Przybelski, Scott A et al. (2018) Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging. Ann Neurol 84:705-716
Eftekharzadeh, Bahareh; Daigle, J Gavin; Kapinos, Larisa E et al. (2018) Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease. Neuron 99:925-940.e7
Lowe, Val J; Lundt, Emily S; Senjem, Matthew L et al. (2018) White Matter Reference Region in PET Studies of 11C-Pittsburgh Compound B Uptake: Effects of Age and Amyloid-? Deposition. J Nucl Med 59:1583-1589

Showing the most recent 10 out of 1014 publications